Home Authors Posts by HealthDay.com

HealthDay.com

23353 POSTS 0 COMMENTS
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 19 to 23

Physician’s Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
The stress of the COVID-19 pandemic

APA: Americans Are Stressed, Particularly Young Adults

American Psychological Association says annual survey points to national mental health crisis
At a meeting of the U.S. Food and Drug Administration vaccine advisory board

FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

Polls show Americans getting more skeptical about a vaccine, worry that approval process is being rushed
When a COVID-19 vaccine becomes available

CDC Plans Cellphone COVID-19 Vaccine Tracking System

Health checks will be done by text messages and email every day during the first week after vaccination

American Society of Anesthesiologists, Oct. 2-5

ANESTHESIOLOGY 2020 The annual meeting of the American Society of Anesthesiologists was held virtually this year from Oct. 2 to 5 and attracted...

American College of Surgeons, Oct. 3-7

The 105th Annual American College of Surgeons Clinical Congress The annual meeting of the American College of Surgeons was held virtually this...
Vaccination coverage with many recommended vaccines is high by age 24 months

CDC: Vaccination Coverage Generally High by Age 24 Months

Coverage with at least two doses of flu vaccine higher for children born 2016 to 2017 versus 2014 to 2015
For patients with moderate COVID-19

Convalescent Plasma Has Limited Benefit for Moderate COVID-19

Randomized phase II trial shows no drop in progression to severe disease, all-cause deaths
For patients with psoriasis

Survival From COVID-19 High in Patients With Psoriasis

Risk for hospitalization increased for patients using nonbiologic systemic therapy versus biologics
Tocilizumab may be beneficial for adults with COVID-19 admitted to the intensive care unit

Findings Conflicted for Benefit of Tocilizumab in COVID-19

One trial shows reduction in mortality, but no evidence of efficacy seen in two additional trials